Wright Medical Group Inc. (WMGI) Thursday reported first-quarter net income of $8.4 million or $0.20 per share, compared to $4.6 million or $0.12 per share in the comparable quarter last year.
Excluding items, adjusted loss for the quarter were $922 thousand or $0.02 per share, compared to adjusted income of $6.5 million or $0.17 per share a year ago.
Revenues for the quarter were of $120.36 million, down from $126.66 million a year ago.
Analysts polled by Thomson Reuters estimated a loss of $0.05 per share on revenues of $121.15 million for the quarter. Analysts' estimates typically exclude special items.
Looking ahead to fiscal year 2013, the company anticipates no change to its previously issued full-year 2013 net sales guidance range of $485 million to $495 million.
Including the impact of the BioMimetic transaction, which closed on March 1, 2013, the company anticipates as adjusted earnings per share, including stock-based compensation, to be in the range of a loss of $0.26 to $0.34 per share.
Earlier, the company expected adjusted earnings, including stock-based compensation, to be in the range of $0.00 to $0.06 per share.
Analysts currently expect loss of $0.29 per share on revenues of $491.26 million for fiscal year 2013.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.